Search clinical trials for: Idiopathic Parkinson's disease

Total 382050 results

Amsterdam UMC, location VUmc
GGZ inGeest; Parnassia Bavo Groep

Terminated

Online Cognitive Training in PD, MS and Depressed Patients Treated With Electroconvulsive Therapy

Multiple Sclerosis | Idiopathic Parkinson's Disease | Elderly Post Electric Convulsive Therapy

Netherlands
Acorda Therapeutics
Michael J. Fox Foundation for Parkinson's Research

Completed

Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes

Idiopathic Parkinson's Disease

Israel, Serbia, United Kingdom
CleveXel Pharma

Completed

Efficacy Phase IIa Study of CVXL-0107 in Advanced Parkinson's Disease

Idiopathic Parkinson Disease

France
University Hospital, Tours

Terminated

Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutical, the [18F] LBT-999 (LBT 999)

Idiopathic Parkinson Disease

France
University Hospital, Lille
France Parkinson Association

Completed

Study of Dysarthria, Swallowing Disorders and Respiratory in Parkinson's Disease (ProdDiGYPark)

Parkinson's Disease

France
Helsinki University Central Hospital
University of Helsinki; Jorvi Hospital; Hyvinkää Hospital; Peijas Hospital

Completed

Intestinal and Nasal Microbiota of Patients With Idiopathic Parkinson's Disease

Parkinson's Disease

Finland
Hospital Santa Marcelina

Unknown

tDCS for Treatment of Depression in Parkinson's Disease

Depression | Idiopathic Parkinson Disease

Brazil
AbbVie (prior sponsor, Abbott)

Completed

Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact (DAPHNE)

Advanced Idiopathic Parkinson's Disease
UCB Biopharma S.P.R.L.
PRA Health Sciences

Completed

Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease (NEUPART)

Idiopathic Parkinson's Disease

Germany, France, Italy, Spain, United Kingdom
david groshar

Unknown

PET/MR Imaging in Patients With Short and Long Standing Parkinson's Disease

Idiopathic Parkinson's Disease
Celavie Bioscences, LLC
Hospital Angeles del Pedregal

Unknown

Parkinsonian Brain Repair Using Human Stem Cells (HSCfPD)

Idiopathic Parkinson Disease

Mexico
University Hospital, Akershus
Solvay Pharmaceuticals

Completed

Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit

Parkinson Disease

Norway
UCB Korea Co., Ltd.

Completed

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Idiopathic Parkinson's Disease

Korea, Republic of
University of Saskatchewan

Unknown

Vascular Abnormalities in Idiopathic Parkinson's Disease (IPD)

Idiopathic Parkinson's Disease

Canada
Huashan Hospital
Boehringer Ingelheim

Completed

The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease

Idiopathic Parkinson's Disease

China
Bial - Portela C S.A.

Completed

Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients. (BIPARKII)

Parkinson's Disease

Portugal
Bial - Portela C S.A.

Completed

Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon

Parkinson's Disease

Portugal
Kyunghee University Medical Center

Completed

Efficacy of Acupuncture and Bee Venom Acupuncture on Patients With Idiopathic Parkinson's Disease

Idiopathic Parkinson's Disease

Korea, Republic of
UCB Pharma

Completed

Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease Patients

IDIOPATHIC PARKINSON'S DISEASE

China
Dr. Sharon Hassin
Tel Aviv University; Sheba Medical Center; Bar-Ilan University, Israel

Unknown

Evidence of Neuroplasticity After Performing a Cognitive Task in Idiopathic Parkinson's Disease Patients

Parkinson Disease

Israel
Duke University
GE Healthcare

Completed

Pilot Study To Assess Effect of Treatment and Adherence in PD Subjects

Parkinson Disease

United States
Natalie Allen
South West Sydney Local Health District

Terminated

Walking Capacity in Parkinson's Disease (PD-Walk)

Idiopathic Parkinson's Disease

Australia
UCB BIOSCIENCES GmbH

Completed

Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain (DOLORES)

Advanced Idiopathic Parkinson's Disease

United States, Germany, Poland, Slovakia
Diskapi Teaching and Research Hospital

Completed

Tizanidine and Pain After Herniorrhaphy

Unilateral Inguinal Hernia

Turkey
Memorial Hospital of Rhode Island

Completed

Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease

Parkinson Disease
Sun Life Financial Movement Disorders Research...

Unknown

Whole-body Vibration as a Treatment for Parkinson's Disease

Idiopathic Parkinson's Disease | Primary Parkinsonism

Canada
ThromboGenics

Completed

A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt)

Vitreomacular Traction

Belgium, Germany
UCB Pharma

Terminated

Long-term Extension of RECOVER- Long-term Effect of the 24h Transdermal Delivery of Rotigotine in Subjects With Idiopathic Parkinson's Disease

Parkinson's Disease

Spain, South Africa, New Zealand, Hungary, United States, Germany, Italy, Australia, Finland, United Kingdom, Poland
UCB Pharma

Completed

Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease

Parkinson's Disease

South Africa
Technische Universität Dresden
University of Wuerzburg

Unknown

Pharmacologically Active Constituents of Chocolate and Their Symptomatic Effects in Patients With Idiopathic Parkinson's Disease (Choc-PD)

Parkinson Disease

Germany
UCB Pharma

Completed

An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease

Idiopathic Parkinson's Disease

United States, Germany, Spain, Austria, Israel, Italy, South Africa, United Kingdom
Universidade Federal de Pernambuco

Unknown

Neuromodulation on Motor Function in Parkinson's Disease

Idiopathic Parkinsons Disease
UCB Pharma

Completed

A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease

Parkinson's Disease

Germany
Boehringer Ingelheim

Completed

Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease

Parkinson Disease
UCB Pharma

Completed

A Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders Idiopathic Parkinson's Disease

IDIOPATHIC PARKINSON'S DISEASE

Germany
Boehringer Ingelheim

Completed

Post Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson's Disease

Parkinson Disease
UCB Pharma

Completed

Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa

Parkinson Disease, Idiopathic

Germany
Boehringer Ingelheim

Completed

Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease

Parkinson Disease
UCB Pharma

Completed

A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease

Parkinson's Disease

United States
Boehringer Ingelheim

Completed

Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's Disease

Parkinson Disease
Boehringer Ingelheim

Completed

The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease

Parkinson Disease
UCB Pharma

Completed

Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor Symptoms

Idiopathic Parkinson's Disease

Germany, Austria, Belgium, Bulgaria, Czech Republic, France, Hungary, Italy, Romania, Slovakia, Spain, Switzerland
UCB BIOSCIENCES GmbH
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease

Advanced Idiopathic Parkinson's Disease

Korea, Republic of, United States, Malaysia, Singapore, Taiwan
ThromboGenics

Completed

Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy

Eye Diseases | Vitreomacular Traction Maculopathy

Belgium, Netherlands
UCB Pharma SA

Terminated

Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's Disease (REFRESH-PD)

Advanced Idiopathic Parkinson's Disease

United Kingdom
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy of Transdermal Nicotine, on Motor Symptoms in Advanced Parkinson's Disease (NICOPARK2)

Idiopathic Parkinson's Disease

France
UCB Pharma

Completed

Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver Support (CARE-ACT)

Idiopathic Parkinson's Disease

Germany
UCB Pharma

Completed

Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias

Idiopathic Parkinson Disease
Newron Pharmaceuticals SPA

Completed

MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist (MOTION)

Idiopathic Parkinson's Disease

United States, Spain, Brazil, Peru, Colombia, Germany, Argentina, India, Croatia, Czech Republic, Italy, South Africa, Finland, Portugal, Canada, Slovakia, Bulgaria, Chile, Mexico, Poland
UCB Pharma GmbH

Completed

Change in Gastrointestinal Complaints After Switch From Oral Parkinson's Disease Treatment to Neupro® Transdermal Patch (NON-GI)

Idiopathic Parkinson's Disease

Germany

3

Subscribe